DS

Devabattini Sai Swetha

Active Director Director DIN 10223734
DIN 10223734 First appointment Jul 2023
Unlock full profile Investments · shareholding · contact details
Current companies 1 active board seats
Total affiliations 1 Since Jul 2023
Shareholding value •••• Premium profile

About Devabattini Sai Swetha

Data last updated:

Devabattini Sai Swetha is a Director at Nextgen Vet Pharma Private Limited (since 2023). Nextgen Vet Pharma Private Limited reported revenue of ₹52.2 Lakh (FY 2024).

DIN 10223734
Primary Designation Director
First Appointment 03 Jul 2023
Oldest Company Age 3 yrs
Largest company Nextgen Vet Pharma Private Limited · ₹52.2 Lakh (FY 2024)

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Nextgen Vet Pharma Private Limited U58122TS2023PTC174585
Director03 Jul 20232023₹52.2 Lakh (FY 2024)Active

Board colleagues of Devabattini Sai Swetha

Directorship timeline

Open interactive timeline →
Nextgen Vet Pharma Private Limited
Premium access

Shareholding and investment profile for Devabattini Sai Swetha

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Devabattini Sai Swetha

Devabattini Sai Swetha currently holds 1 directorship: Nextgen Vet Pharma Private Limited (Director, since 03 Jul 2023, revenue ₹52.2 Lakh (FY 2024)).

Devabattini Sai Swetha was first appointed on 03 Jul 2023 as Director at Nextgen Vet Pharma Private Limited.

The current boards of Devabattini Sai Swetha's companies include Mohan Rao Pilla (Nextgen Vet Pharma Private Limited), Raavi Venkata Ramayya (Nextgen Vet Pharma Private Limited).

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available